Initial results from a phase 2 trial of AMG 706 in patients (Pts) with medullary thyroid cancer (MTC)

Schlumberger, M.; Daumerie, Chantal; Elisei, R.; Sherman, S.; Bastholt, L.; Wirth, L.; Martins, R.; Licitra, L.; Jarzab, B.; Pacini, F.; Droz, J. P.; Shi, Y.; Sun, Y. -N.; Stepan, D.

Initial results from a phase 2 trial of AMG 706 in patients (Pts) with medullary thyroid cancer (MTC)

Schlumberger, M.

;

Daumerie, Chantal

;

Elisei, R.

;

Sherman, S.

;

Stepan, D.

;et.al.

(2007) 32nd Annual Meeting of the European Thyroid Association — Location: Leipzig (DE) (1.September.2007)

Files

No attached file found for this publication.

Details

Authors

Schlumberger, M.
Author
Daumerie, ChantalUCLouvain
Author
Elisei, R.
Author
Sherman, S.
Author
Stepan, D.
Author

Affiliations

UCLouvainCliniques universitaires Saint-Luc
UCLouvainMD/MINT - Département de médecine interne

Citations

APA
Chicago
FWB

Schlumberger, M., Daumerie, C., Elisei, R., Sherman, S., Bastholt, L., Wirth, L., Martins, R., Licitra, L., Jarzab, B., Pacini, F., Droz, J. P., Shi, Y., Sun, Y.-N., & Stepan, D. (2007). Initial results from a phase 2 trial of AMG 706 in patients (Pts) with medullary thyroid cancer (MTC). Hormone Research, 68(Suppl. 3), 5. https://hdl.handle.net/2078.5/148275 (Original work published 2007)